Ligand Pharmaceuticals, Inc. (NASDAQ:LGND)

CAPS Rating: 4 out of 5

Develops and markets new drugs that address critical unmet medical needs in the areas of cancer, mens and womens health, skin diseases, osteoporosis, and metabolic, cardiovascular and inflammatory diseases.

Recs

0
Player Avatar tixareforkids (93.29) Submitted: 4/15/2009 12:25:12 PM : Outperform Start Price: $17.10 LGND Score: -82.92

zz

Featured Broker Partners


Advertisement